Boris Nikolic, Director at Editas Medicine, Inc. (EDIT), bought 35,000 shares at $14.07 ($492K) on 2017-06-02, disclosed to the SEC on 2017-06-06.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.